COVID-19

COVID-19 Evidence Alerts
from McMaster PLUSTM

Current best evidence for clinical care (more info)

Treatment Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, et al. Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 1). Ann Intern Med. 2021 Feb;174(2):229-236. doi: 10.7326/M20-5831. Epub 2020 Oct 5.
Access free full-text from publisher View on PubMed Read rater comments
Abstract

These rapid and living practice points from the American College of Physicians address the effectiveness and harms of remdesivir treatment in patients with COVID-19.

Ratings
Discipline / Specialty Area Score
Infectious Disease
Intensivist/Critical Care
Respirology/Pulmonology
Hospital Doctor/Hospitalists
Internal Medicine
Comments from MORE raters

Internal Medicine rater

This is only useful for those treating patients with COVID-19.

Internal Medicine rater

COVID-19 pandemic is far from over. Any little improvement in patient outcome brings a ray of hope. It is worth considering 10-day course of Remdesvir for who are still on mechanical ventilation at the end of 5 days of Remdesvir therapy.